Tameka RIdout

Tameka Ridout serves as a procurement professional responsible for managing acquisitions critical to the healthcare supply chain, with a focus on medical equipment, pharmaceuticals, and botanical-derived therapeutics. She plays a central role in executing agency procurement strategies that ensure timely access to essential medical supplies and manufactured pharmaceutical products. Her portfolio includes complex solicitations under Federal Acquisition Regulation (FAR) Part 13 and Part 15, often involving sealed bidding and negotiated contracting methods. Ridout’s work supports mission-critical operations by securing high-integrity medical commodities through compliant, transparent, and efficient acquisition processes. Her contractor relationships are primarily with merchant wholesalers and manufacturers specializing in medical, dental, and hospital supplies, as well as pharmaceutical preparation and botanical manufacturing firms. She engages with a diverse base of vendors, including large-scale distributors and niche producers, ensuring robust competition and supply chain resilience. While no single contractor dominates her award profile, her contracting patterns reflect a preference for established suppliers with proven regulatory compliance, quality control systems, and distribution capabilities aligned with FDA and GMP standards. Ridout’s procurement activity is entirely non-set-aside, with 100% of her acquisitions conducted under full and open competition. This reflects a strategic focus on maximizing market participation and leveraging broad industry capacity rather than targeting specific socioeconomic categories. Her approach prioritizes technical merit, delivery reliability, and regulatory adherence over socioeconomic preferences, aligning with agency mandates for efficiency and scale in critical healthcare procurement. Her primary NAICS focus spans medical equipment wholesale (423450), medicinal and botanical manufacturing (325411), and pharmaceutical preparation (325412), indicating deep expertise in procuring sterile injectables, diagnostic supplies, and plant-based therapeutics. She routinely evaluates technical specifications for compliance with USP, ASTM, and ISO standards, demonstrating specialized knowledge in pharmaceutical logistics, cold chain requirements, and medical device classification under FDA regulations.